Patent US5236824A successfully refreshed from Google Patents.
US5236824A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Laser magnetic immunoassay method and method by a magnetophoresis apparatus therefor
Assignee: NTT Inc
•
Filing: 1991-12-18
•
Granted: 1993-08-17
•
Expires: 2011-12-18
Abstract
Abstract An in-situ laser magnetic immunoassay ("LMIA") method which eliminates the step of B/F separation generally required in the labeling method of immunoassays. The laser magnetic immunoassay permits a quantitative determination of a target immunological substance, for example, an antigen, an antibody, lymphocytes, viruses, tumorous cells and infections cells, in an analyte solution containing both bound and free species. A transitory increase in the magnetophoretic scattering of laser beam is observed when the analyte solution contains magnetic-labeled, bound target analyte, while no such increase is observed in a control test solution, containing only the relevant reagents. A magnetophoretic LMIA apparatus is provided which includes a magnetic gradient generating device which forms an integral part of the in-situ LMIA.
Inventors
- 👤 Koichi Fujiwara
- 👤 Hiroko Mizutani
- 👤 Hiromichi Mizutani, deceased
- 👤 Shuichi Shibata
- 👤 Koichi Arishima
- 👤 Mitsutoshi Hoshino
- 👤 Yasushi Hoshino
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 19:23
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/58; G01N33/585; G01N33/53; G01N33/543; G01N33/54313; G01N33/54326; G01N35/00; G01N35/0098; Y; Y10; Y10S; Y10S436/00; Y10S436/805; Y10S436/806; Y10S436/811; Y10S436/813; Y10S436/815; Y10S436/817
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
210 words
A laser magnetic immunoassay method comprising: (a) preparing a buffer solution containing a target body comprising an antibody or antigen; (b) preparing a reagent solution containing magnetic-labeled antigen or antibody by affixing an antigen or antibody which specifically binds to said target body to magnetic particles; (c) reacting said buffer solution with said reagent solution containing magnetic-labeled antigen or antibody so as to form a reacted solution consisting essentially of a magnetic-labeled antigen or antibody bound to said target body, and magnetic-labeled free antigen or antibody; (d) injecting said reacted solution into a lower magnetic field end of a magnetophoretic tube disposed inside a magnetic field generating means; (e) radiating a laser beam on a strong magnetic field end of sai magnetophoretic tube; (f) applying a unidirectional gradient magnetic field to said magnetophoretic tube during step (e); (g) detecting and measuring scattered or transmitted outgoing light from said magnetophoretic tube; and (h) conducting an in-situ determination of the quantity of said target body according to a transient rise in scattered or transmitted outgoing light caused by said magnetic-labeled antigen or antibody bound to said target body reaching a position of concentration at the strong magnetic field end of said magnetophoretic tube more quickly than said magnetic-labeled free antigen or antibody.
Claim 2
Dependent Claim
210 words
A laser magnetic immunoassay method comprising: (a) preparing a buffer solution containing a target body comprising an antibody or antigen; (b) preparing a reagent solution containing magnetic-labeled antigen or antibody by affixing an antigen or antibody which specifically binds to said target body to magnetic particles; (c) reacting said buffer solution with said reagent solution containing magnetic-labeled antigen or antibody so as to form a reacted solution consisting essentially of a magnetic-labeled antigen or antibody bound to said target body, and magnetic-labeled free antigen or antibody; (d) injecting said reacted solution into a lower magnetic field end of a magnetophoretic tube disposed inside a magnetic field generating means; (e) radiating a laser beam on a strong magnetic field end of sai magnetophoretic tube; (f) applying a unidirectional gradient magnetic field to said magnetophoretic tube during step (e); (g) detecting and measuring scattered or transmitted outgoing light from said magnetophoretic tube; and (h) conducting an in-situ determination of the quantity of said target body according to a transient rise in scattered or transmitted outgoing light caused by said magnetic-labeled antigen or antibody bound to said target body reaching a position of concentration at the strong magnetic field end of said magnetophoretic tube more quickly than said magnetic-labeled free antigen or antibody.
Claim 3
Dependent Claim
17 words
The laser magnetic immunoassay magnetic method claimed in claim 1 wherein said magnetic particles are ferromagnetic particles.
Claim 4
Dependent Claim
18 words
The laser magnetic immunoassay magnetic method as claimed in claim 1, wherein said magnetic particles are superparamagnetic particles.
Claim 5
Dependent Claim
19 words
The laser magnetic immunoassay magnetic method as claimed in claim 1, wherein said target body is a lymphocyte antigen.
Claim 6
Dependent Claim
19 words
The laser magnetic immunoassay magnetic method as claimed in claim 1, where said target body is a viral antigen.
Claim 7
Dependent Claim
19 words
The laser magnetic immunoassay magnetic method as claimed in claim 1, wherein said target body is a tumor cell.
Claim 8
Dependent Claim
20 words
The laser magnetic immunoassay magnetic method as claimed in claim 1, wherein said target body is an infectious cellular organism.
Claim 9
Dependent Claim
19 words
The laser magnetic immunoassay magnetic method as claimed in claim 1, wherein said target body is a hormonal antigen.
Claim 10
Dependent Claim
56 words
The laser magnetic immunoassay as claimed in claim 1, wherein said magnetic particles are selected from the group consisting of ferromagnetic particles and superparamagnetic particles and the target body is selected from the group consisting of a lymphocyte antigen, a viral antigen, a viral antibody, a tumor cell, an infectious cellular organism and a hormonal antigen.
Claim 11
Dependent Claim
29 words
The laser magnetic immunoassay as claimed in claim 9, wherein the determination of the quantity of said target body is performed serially and automatically on a plurality of specimens.
Claim 12
Dependent Claim
247 words
A laser magnetic immunoassay apparatus for performing an in-situ analysis of an immunoreaction, said apparatus comprising: (a) a magnetic field gradient generating means for generating a unidirectional magnetic field gradient; (b) a magnetophoretic tube disposed inside said magnetic field gradient generating means; (c) an incident optical system for guiding a laser beam from a laser beam source to a selected position of a strong magnetic field end of said magnetophoretic tube; (d) an optical system for receiving scattered or transmitted outgoing light from said magnetophoretic tube containing magnetic-labeled antigen or antibody bound to a target body and magnetic-labeled free antigen or antibody; (e) an electronic control means for analyzing the response characteristics including a transient rise of the scattered or transmitted outgoing light intensity caused by said magnetic-labeled antigen or antibody bound to said target body reaching a position of concentration at the strong magnetic field end of said magnetophoretic tube more quickly than said magnetic labeled free antigen or antibody; (f) a first injecting means for injecting said magnetic-labeled antigen or antibody bound to said target body and said magnetic-labeled free antigen or antibody into an inlet of a weak mangetic field end of the magnetophoretic tube; and (g) a second injecting means for injecting a non-magnetic solvent into the magnetophoretic tube, thereby permitting an in-situ quantitative determination of the magnetic-labeled bound target body in a reacted solution containing the magnetic-labeled antigen or antibody bound to said target body and the magnetic-labeled free antigen or antibody.
Claim 13
Dependent Claim
247 words
A laser magnetic immunoassay apparatus for performing an in-situ analysis of an immunoreaction, said apparatus comprising: (a) a magnetic field gradient generating means for generating a unidirectional magnetic field gradient; (b) a magnetophoretic tube disposed inside said magnetic field gradient generating means; (c) an incident optical system for guiding a laser beam from a laser beam source to a selected position of a strong magnetic field end of said magnetophoretic tube; (d) an optical system for receiving scattered or transmitted outgoing light from said magnetophoretic tube containing magnetic-labeled antigen or antibody bound to a target body and magnetic-labeled free antigen or antibody; (e) an electronic control means for analyzing the response characteristics including a transient rise of the scattered or transmitted outgoing light intensity caused by said magnetic-labeled antigen or antibody bound to said target body reaching a position of concentration at the strong magnetic field end of said magnetophoretic tube more quickly than said magnetic labeled free antigen or antibody; (f) a first injecting means for injecting said magnetic-labeled antigen or antibody bound to said target body and said magnetic-labeled free antigen or antibody into an inlet of a weak mangetic field end of the magnetophoretic tube; and (g) a second injecting means for injecting a non-magnetic solvent into the magnetophoretic tube, thereby permitting an in-situ quantitative determination of the magnetic-labeled bound target body in a reacted solution containing the magnetic-labeled antigen or antibody bound to said target body and the magnetic-labeled free antigen or antibody.
Claim 14
Dependent Claim
17 words
The laser magnetic immunoassay as claimed in claim 1, wherein said target body is a viral antibody.
References Cited (Backward Citations)
US3970518A
Cited
US4141687A
Cited
US4177253A
Cited
US4297337A
Cited
US4454234A
Cited
US4452773A
Cited
US4672040A
Cited
EP0125995A2
Cited
US4582622A
Cited
JPS61128168A
Cited
WO1987002063A1
Cited
JPS62118255A
Cited
US4935147A
Cited
JPS62287159A
Cited
WO1988002118A1
Cited
JPS6379070A
Cited
EP0287665A1
Cited
JPS63106559A
Cited
JPS63108265A
Cited
JPS63188764A
Cited
JPS63188766A
Cited
JPS63315951A
Cited
JPS63315952A
Cited
US4913883A
Cited
JPS6429768A
Cited
JPH01107151A
Cited
JPH01109263A
Cited
JPH01182755A
Cited
JPH01272973A
Cited
JPH01272971A
Cited
JPH01272968A
Cited
JPH01272972A
Cited
JPH01272969A
Cited
JPH01321362A
Cited
JPH01321363A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-08-16 | 1997-02-15 | 1997-08-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-08-16 | 2001-02-15 | 2001-08-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-08-16 | 2005-02-15 | 2005-08-17 | $7700.00 | Window Closed / Lapsed |